Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001384263 | SCV001583692 | pathogenic | Mucopolysaccharidosis, MPS-III-A | 2024-05-15 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 182 of the SGSH protein (p.Arg182His). This variant is present in population databases (rs372911015, gnomAD 0.01%). This missense change has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 31718697). ClinVar contains an entry for this variant (Variation ID: 1071734). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SGSH protein function with a positive predictive value of 80%. This variant disrupts the p.Arg182 amino acid residue in SGSH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9554748, 10727844, 21061399, 30809705). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Neuberg Centre For Genomic Medicine, |
RCV001384263 | SCV004175842 | likely pathogenic | Mucopolysaccharidosis, MPS-III-A | 2023-02-14 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001384263 | SCV004201091 | likely pathogenic | Mucopolysaccharidosis, MPS-III-A | 2024-03-28 | criteria provided, single submitter | clinical testing |